Numeral (JSE:XII) ROC (Joel Greenblatt) %: -242.96% (As of Nov. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

JSE:XII Numeral Ltd JSE:XII
10 GF Score
Price R0.30
! 5 Warning Signs
View Full Analysis

What is Numeral ROC (Joel Greenblatt) %?

Numeral JSE:XII 10 ROC (Joel Greenblatt) % is -242.96% as of Nov. 2025. GuruFocus rates JSE:XII with a GF Score™ of 10/100. The stock has 5 warning signs investors should review. Among 983 Drug Manufacturers companies, Numeral ranks better than 87.39% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Numeral's annualized ROC (Joel Greenblatt) % for the quarter that ended in Nov. 2025 was -242.96%.

The historical rank and industry rank for Numeral's ROC (Joel Greenblatt) % or its related term are showing as below:

JSE:XII' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -0.94   Med: 13.23   Max: 105.36
Current: 57.41

During the past 13 years, Numeral's highest ROC (Joel Greenblatt) % was 105.36%. The lowest was -0.94%. And the median was 13.23%.

JSE:XII's ROC (Joel Greenblatt) % is ranked better than
87.39% of 983 companies
in the Drug Manufacturers industry
Industry Median: 11.46 vs JSE:XII: 57.41

Numeral's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Numeral  (JSE:XII) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Numeral ROC (Joel Greenblatt) % Related Terms


Numeral ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Numeral's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Numeral ROC (Joel Greenblatt) % Chart

Numeral Annual Data
Trend Dec14 Dec15 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 105.35

Numeral Quarterly Data
Aug20 Nov20 Feb21 Aug21 Nov21 Feb22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 193.58 74.54 302.28 240.61 -242.96

JSE:XII vs ZTS, UTHR, VTRS: ROC (Joel Greenblatt) % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Numeral's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Numeral ROC (Joel Greenblatt) % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Numeral's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Numeral's ROC (Joel Greenblatt) % falls into.


JSE:XII
10GF Score
Numeral Ltd JSE:XII
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Numeral ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Aug. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(22.668 + 0.956 + 0) - (10.653 + 0 + 0.778)
=12.193

Working Capital(Q: Nov. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(20.745 + 1.413 + 0.017000000000003) - (6.582 + 0 + 0.741)
=14.852

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Numeral for the quarter that ended in Nov. 2025 can be restated as:

ROC (Joel Greenblatt) %(Q: Nov. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Aug. 2025  Q: Nov. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-38.664/( ( (2.354 + max(12.193, 0)) + (2.429 + max(14.852, 0)) )/ 2 )
=-38.664/( ( 14.547 + 17.281 )/ 2 )
=-38.664/15.914
=-242.96 %

Note: The EBIT data used here is four times the quarterly (Nov. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of -242.96% mean?
Numeral (JSE:XII) has a ROC (Joel Greenblatt) % of -242.96% as of Nov. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Numeral and its competitors. According to the industry distribution chart, Numeral ranks #124 out of 983 companies in the Drug Manufacturers industry, placing it in the top 12.6%.
Is Numeral's ROC (Joel Greenblatt) % too high?
Numeral's current ROC (Joel Greenblatt) % is -242.96%. Based on the distribution chart, Numeral ranks #124 out of 983 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Numeral has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Numeral's ROC (Joel Greenblatt) % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Numeral ranks #124 out of 983 companies for ROC (Joel Greenblatt) %. This places Numeral in the top 13% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 11.46. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Drug Manufacturers company?
The median ROC (Joel Greenblatt) % among Drug Manufacturers companies is 11.46, based on 983 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Numeral and its competitors. For the Drug Manufacturers industry, the median ROC (Joel Greenblatt) % is 11.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Numeral's current ROC (Joel Greenblatt) % is -242.96%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Numeral stock overvalued right now?
Numeral (JSE:XII) has a current ROC (Joel Greenblatt) % of -242.96%. The current ROC (Joel Greenblatt) % is -242.96%. Numeral's overall GF Score™ is 10/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Numeral (JSE:XII), the current ROC (Joel Greenblatt) % is -242.96% as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Numeral Business Description

Other Exchanges NXII.N0000:Mauritius
Address Sayed Hossen Road, Unit 13 Socota Phoenicia, Phoenix, MUS
Numeral Ltd is an investment holding company based in Mauritius with a focus on fintech, biotechnology, and asset management. Geographically it has a presence in countries across Africa, Europe and Asia. The majority of its revenue is generated in the form of Trading income.
10GF Score

Get the complete analysis for JSE:XII

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R0.30
Price